GOODWILL AND INTANGIBLE ASSETS (Changes in Carrying Amount of Goodwill) (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2025 |
Dec. 31, 2024 |
|
Goodwill [Line Items] | ||
Balance as of January 1 | $ 6,369.7 | |
Goodwill, Acquired During Period | 36.4 | |
Foreign currency impact and other adjustments to Goodwill | 15.0 | |
Balance at end of period | 6,421.1 | |
Goodwill Impairment, Cumulative | 648.5 | $ 648.5 |
LabCorp Diagnostics [Member] | ||
Goodwill [Line Items] | ||
Balance as of January 1 | 5,102.5 | |
Goodwill, Acquired During Period | 36.4 | |
Foreign currency impact and other adjustments to Goodwill | (7.3) | |
Balance at end of period | 5,131.6 | |
Covance Drug Development [Member] | ||
Goodwill [Line Items] | ||
Balance as of January 1 | 1,267.2 | |
Goodwill, Acquired During Period | 0.0 | |
Foreign currency impact and other adjustments to Goodwill | 22.3 | |
Balance at end of period | $ 1,289.5 |
X | ||||||||||
- Definition Goodwill Impairment, Cumulative No definition available.
|
X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of increase (decrease) from foreign currency translation and measurement period adjustments of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|